Does lion's mane improve memory?
Short answer
Unclear. Only four trials, with mixed results.
Only four human trials tested memory or thinking, and the two that report size had 30 and 41 people. One found better scores in older adults; others improved only some tests.
This page says what the research shows. It does not say whether you should take lion's mane.
Where the evidence stands
Each dot is one on-topic paper. Steps near the top answer the question more directly. Select a dot to see the study.
↑ Stronger evidence
-
Trials in people: memory and thinking
Trials that measured memory and thinking directly.
4 -
Trials in people: other measures
Trials that measured other health or performance measures.
0None among the papers we read.
-
Trials in people: lab tests or safety
Trials that measured lab tests, side effects or safety.
0None among the papers we read.
-
Population studies
Studies that followed or surveyed groups of people. They show links, not causes.
0None among the papers we read.
-
Blood levels and genes
Studies that link blood levels or genes to health.
0None among the papers we read.
-
Animals
Studies in mice, rats, worms or flies.
1
↓ Weaker evidence
- Points to benefit
- Mixed
- No difference
- No direction
- Points to harm
Not on the ladder: 1 review of many studies (shown below). Counts are papers, not people. Some studies appear in more than one paper.
See every studyWhat we found
- Only 14 papers exist on this question. Four are human trials of memory or thinking; the two that report size had 30 and 41 people. Mori 2009, Saitsu 2019, Docherty 2023, La Monica 2023
- In 30 adults aged 50 to 80 with mild memory and thinking problems, 16 weeks of lion's mane tablets raised test scores above placebo. Scores fell after stopping. Mori 2009
- In two other trials, one dose of lion's mane (1.8 g or 1 g) made people faster on some thinking tasks but not on others. Docherty 2023, La Monica 2023
- The only review pooled one trial and one pilot trial: memory and thinking test scores rose by a combined average of 1.17 with lion's mane. Menon 2025
What the research says
Longer trials: gains on some memory tests
Over 16 weeks, 30 adults aged 50 to 80 with mild memory and thinking problems took lion's mane tablets (four 250 mg tablets, three times a day) or placebo. The lion's mane group scored higher at weeks 8, 12 and 16. Four weeks after stopping, scores fell.
A second trial gave a lion's mane supplement or placebo for 12 weeks. Scores were better on one of three tests, the Mini Mental State Examination. The abstract does not give the number of people, their ages or the dose.
Studies: Mori 2009, Saitsu 2019
One dose: faster on some thinking tasks
In 41 healthy adults aged 18-45, one 1.8 g dose made people quicker on a thinking task (Stroop) 60 min later. The authors also report results with no change and a few negative ones, and warn that the sample was small.
In a trial where each person tried all three, one 1 g dose of lion's mane was compared with a guayusa extract and placebo. Lion's mane improved attempts on a counting task and reaction time on two others. Guayusa improved more measures. The abstract gives no number of people.
Studies: Docherty 2023, La Monica 2023
The one review pools just two studies
A 2025 review found five randomized trials and three pilot trials of lion's mane and thinking, in people with and without dementia. Pooling one trial and one pilot trial, Mini-Mental State Examination scores rose by a combined average of 1.17 with lion's mane.
The review concludes lion's mane enhances thinking. The trials here are more mixed: most improved only some tests. The review lists possible side effects: stomach discomfort, headache and allergic reactions.
Studies: Menon 2025
In mice, memory did not improve
Mice bred to develop Alzheimer-type brain changes ate a diet with lion's mane for 4.5 months. They acted less anxious, but their spatial memory and daily-living behaviors did not improve. Mouse results may not hold in people.
Studies: Rodriguez 2022
What reviews of many studies found
Reviews pool or sum up earlier studies. They are not on the ladder, because they repeat studies already counted there.
Systematic review · Menon 2025
Covered five randomized trials, three pilot trials, 15 lab studies and three others (2000 to June 2024). Pooling one trial and one pilot, memory and thinking test scores rose by 1.17. It concluded lion's mane enhances thinking.
How the research grew
The papers we read span 2009 to 2025. 1 of the 6 on-topic papers came out in 2024 to 2026. The earliest trial in people here is from 2009.
- 2009
- 2019
- 2022
- 2023
- 2025
Each dot is one on-topic paper, colored by what it found. Rings mark key papers:
- 2009. First human trial: 30 older adults, 16 weeks. Mori 2009
- 2019. Second longer trial; better on one of three tests. Saitsu 2019
- 2023. Largest stated trial: 41 healthy young adults. Docherty 2023
- 2025. Only review; pools memory test scores from two studies. Menon 2025
Who was studied
Who took part, and how many. The largest trial here had 41 people.
- Trials in people
- People in the study, log scale110100
- Points to benefit
- Mixed
- No difference
- No direction
- Points to harm
Bars use a log scale: each step is ten times more people. Reviews, animal studies and papers with no count in the abstract are not shown.
Who funds this research
Of four trial papers, two have a company stake: Sempera Organics supplied the product for one, and Applied Food Sciences funded another. The other two trials give no disclosure in PubMed. Stakes did not lower the confidence, since not every supporting study has one.
- Company stake 2
- No disclosure in PubMed 2
- Docherty 2023Company stake
- La Monica 2023Company stake
- Saitsu 2019No disclosure in PubMed
- Mori 2009No disclosure in PubMed
Funding rule. A stake is always shown. Confidence is lowered only when every supporting study comes from a party with a stake. "No disclosure in PubMed" means the PubMed record has no conflict-of-interest statement. It does not mean there is no conflict.
All 6 on-topic papers
Each paper shows what it tested, what it found, and who has a stake. Every paper also has its own page that explains how much it counts and how it fits. See every study as a list.
-
The Acute and Chronic Effects of Lion's Mane Mushroom Supplementation on Cognitive Function, Stress and Mood in Young Adults: A Double-Blind, Parallel Groups, Pilot Study.
41 people · Healthy adults aged 18-45
Tested1.8 g lion's mane as one dose (tested 60 minutes later) and over 28 days, vs placebo. How often it was taken is not stated.
One 1.8 g dose made people quicker on the Stroop task at 60 min (p = 0.005). After 28 days, stress showed only a trend down (p = 0.051). Other results showed no change or were slightly negative.
MixedCompany stakeAbstract onlyAuthors declare no conflict, but Sempera Organics supplied the lion's mane product.
-
Acute Effects of Naturally Occurring Guayusa Tea and Nordic Lion's Mane Extracts on Cognitive Performance.
Adults (number and age not given in abstract) tested on thinking tasks
TestedOne dose of 1 g Nordic lion's mane, vs 650 mg guayusa extract, vs placebo, in a crossover design; tested 1 and 2 hours later
One 1 g dose of lion's mane improved attempts on Serial 7s, reaction time on N-Back and Go reaction time on Go/No-go (p ≤ 0.05). Guayusa improved more measures than lion's mane.
MixedCompany stakeAbstract onlyFunded by Applied Food Sciences; one author reports funding and fees from supplement companies.
-
Randomized trial · measured the question itselfSaitsu et al., 2019Biomedical research (Tokyo, Japan) · PubMed
Improvement of cognitive functions by oral intake of Hericium erinaceus.
Adults tested for memory and thinking (number and age not given in abstract)
TestedSupplement made from lion's mane fruiting body for 12 weeks, vs placebo
Three tests were done. On the Mini Mental State Examination alone, scores were better with lion's mane. The other two tests (Benton visual retention, verbal paired-associate learning) are not reported as better.
MixedNo disclosure in PubMedAbstract onlyNo disclosure in PubMed.
-
Randomized trial · measured the question itselfMori et al., 2009Phytotherapy research : PTR · PubMed
Improving effects of the mushroom Yamabushitake (Hericium erinaceus) on mild cognitive impairment: a double-blind placebo-controlled clinical trial.
30 people · Japanese adults aged 50 to 80 with mild cognitive impairment
TestedFour 250 mg tablets, three times a day (3 g a day) for 16 weeks, vs placebo
At weeks 8, 12 and 16 the lion's mane group scored higher than placebo on a memory and thinking scale (HDS-R). At week 4 after stopping, scores fell. Lab tests showed no harmful effect.
Points to benefitNo disclosure in PubMedAbstract onlyNo disclosure in PubMed.
-
Lion's Mane (Hericium erinaceus) Exerts Anxiolytic Effects in the rTg4510 Tau Mouse Model.
Mice bred to develop Alzheimer-type brain changes
TestedDiet with lion's mane for 4.5 months, vs standard diet
Treated mice were less anxious in two tests. No improvements were seen in spatial memory or activities of daily living.
No differenceNo stake declaredAbstract onlyNo competing interests declared.
-
Benefits, side effects, and uses of Hericium erinaceus as a supplement: a systematic review.
26 studies · People with and without dementia in trials, plus lab, cell and other studies
TestedLion's mane in 5 randomized trials, 3 pilot trials, 15 lab studies, 1 cohort study, 1 case report and 1 computer analysis
Scores on a memory and thinking test (Mini-Mental State Examination) from one randomized trial and one pilot trial rose by a combined weighted mean of 1.17 in the lion's mane group. Possible side effects: stomach discomfort, headache, allergic reactions.
Points to benefitNo stake declaredAbstract onlyNo competing interests declared.
8 papers we read and set aside as off topic
- Gong et al., 2025. Edible and Medicinal Fungi as Candidate Natural Antidepressants: Mechanisms and Nutritional Implications. (systematic review)
- Kocatürk et al., 2023. Effect of nutritional supports on malnutrition, cognition, function and biomarkers of Alzheimer's disease: a systematic review. (systematic review)
- Nagano et al., 2010. Reduction of depression and anxiety by 4 weeks Hericium erinaceus intake. (randomized trial)
- Li et al., 2021. Liver and Brain Protective Effect of Sulfated Polysaccharides from Residue of Lion's Mane Medicinal Mushroom, Hericium erinaceus (Agaricomycetes), on D-Galactose-Induced Aging Mice. (animal study)
- Chau et al., 2023. Hericium erinaceus Promotes Anti-Inflammatory Effects and Regulation of Metabolites in an Animal Model of Cerebellar Ataxia. (animal study)
- Priori et al., 2023. Hericium erinaceus Extract Exerts Beneficial Effects on Gut-Neuroinflammaging-Cognitive Axis in Elderly Mice. (animal study)
- Guan et al., 2024. Structural characterization of Hericium coralloides polysaccharide and its neuroprotective function in Alzheimer's disease. (animal study)
- Zhu et al., 2022. RETRACTED: Improvement of extraction from Hericium erinaceus on the gut-brain axis in AD-like mice. (animal study)
Words on this page
- p-value (p =)
- How likely a result this large would be by chance if there were no real effect. Below 0.05 is usually called a clear result.
- Placebo
- A dummy pill or fake treatment, so people do not know which group they are in.
- Pooled review (meta-analysis)
- A study that combines the results of many earlier studies to get one overall answer.
- Cohort study
- A study that follows a large group of people over years. It shows links, not causes.
How the short answer is set
Fixed rules turn the studies into the short answer, so the same studies always give the same answer. The rules start from GRADE, a standard system for rating evidence, in plain language.
| Confidence | What it means |
|---|---|
| High | We are confident the answer is right. |
| Moderate | The answer is probably right, but it could change. |
| Low | The answer may well change. |
| Very low (this page) | Any answer is very uncertain. |
| Not tested in people | Only cell or animal studies exist. |
Why very low here
- Only four human trials; the two that report size had 30 and 41 people.
- Results are mixed: most trials improved only one or a few of several tests.
- Abstracts give almost no effect sizes or ranges, so any benefit's size is unclear.
- Two trials tested a single dose; the longest trial lasted 16 weeks.
How this page was made
Label
- Search
- PubMed, Nov 14, 2026. Searches written by Claude Opus 5.5; papers ranked by PubMed
- First read of all 14 papers
- Claude Sonnet
- Independent second read
- Claude Haiku
- Disagreements settled by
- Claude Opus 5.5
- Page text written by
- Claude Opus 5.5
- Charts
- Drawn by code from the study records
- Source check by a person
- Not yet. Required before search engines may list this page.
- Expert review
- No
- Papers read in full
- 0 of 14; all from PubMed abstracts
- Method
- v0.2, created Nov 14, 2026
Search. We ran four PubMed searches for lion's mane mushroom and memory and thinking: pooled and systematic reviews since 2012 (3 of 3), trials in people (5 of 5), population studies (0 of 0), animal studies (6 of 39). The first number is how many papers we read; the second is how many PubMed found. We took the ones PubMed ranks as most relevant. See the full PubMed search. Of the 14 papers read, 6 were on topic.
Limits. Digestery reads at most about 60 papers per question, so large fields are sampled, not covered in full. Abstracts can leave out key details, such as side effects and funding.
Review queue
These items wait for a person. Search engines are asked not to list the page until the first one is done.
- OpenThe short answer is new. It waits for a source check by a person.
- OpenRetracted: Zhu 2022 (Zhu 2022, mouse study) was retracted for reused data. It is not counted as evidence.
- OpenMenon review Menon 2025 pooled one trial and one pilot trial; these may be Mori Mori 2009 or Saitsu Saitsu 2019. Check for double counting.
- OpenSaitsu Saitsu 2019 and La Monica La Monica 2023 abstracts give no number of people or ages; Saitsu gives no dose. Check full texts.
- OpenDocherty Docherty 2023: abstract does not say the 1.8 g was taken daily over 28 days. Check the dose in the full text.
- OpenLa Monica La Monica 2023: unclear whether lion's mane gains were measured against placebo or against each person's starting score.
- OpenMori Mori 2009 and Saitsu Saitsu 2019 have no conflict statement in PubMed, so company ties are unknown.
- OpenKocatürk review Kocatürk 2023 says lion's mane mycelia improved cognition in Alzheimer's; excluded as a many-supplement review. Confirm the exclusion.
- OpenGuan Guan 2024 tested Hericium coralloides, not lion's mane; excluded under the topic rule even though mouse memory improved.
- OpenMenon Menon 2025 pools two studies but is typed systematic_review; confirm whether it should count as a meta-analysis.
Page history
| Date | Change | Reason |
|---|---|---|
| Nov 14, 2026 | Page created from 14 papers. | First version of the page. |
Flag an error
A flag must point to a source: the passage in the paper, or a link to a study this page missed. A flag starts a new check. Votes never change a page.